The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services today announced it has identified a fraud scheme targeting Medicare providers and suppliers. CMS said scammers…
Headline
Boston Medical Center’s Jeff Schneider, M.D., associate chief medical officer, designated institutional official and chair of the Graduate Medical Education…
Perspective
In the next few days, Senate Republican leaders plan to unveil and vote on their updated reconciliation bill, which, as currently constructed, would have far-…
Headline
The AHA today commented to House and Senate appropriations committee leaders on funding for health care programs in the fiscal year 2026 appropriations bill.…
Headline
Coalition ad links decisions on Medicaid cuts by Congress to impacts on hospitalsA new television and digital advertisement launched today by the Coalition to…
Perspective
Public
As the Senate eyes a vote next week on its reconciliation bill, the next few days are crucial for reaching out to your senators and urging them to make changes…